Fig. 2 | Scientific Reports

Fig. 2

From: Changes of T cell subsets across treatments associated with prognosis in newly diagnosed follicular lymphoma

Fig. 2The alternative text for this image may have been generated using AI.

Longitudinal changes in (A) CD3+, (B) CD4+, (C) CD8 + T cell subsets, and (D) CD4/8 ratio across treatment in FL patients. * P < 0.05, ** P < 0.01, ***P < 0.001, ****P < 0.0001. Further, changes in (E) CD3+, (F) CD4+, (G) CD8 + T cell counts, and (H) CD4/8 ratio were compared between FL patients using the Bendamustine-based (B-based) regimen and the Non-B-based regimen.

Back to article page